GSK3352589
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK3352589, covering 2019-08-09 to 2019-08-09. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1, First Time in Human (FTIH) Study to Evaluate GSK3352589, a REarranged During Transfection (RET) Growth Factor Receptor Tyrosine Kinase Inhibitor, in Healthy Volunteers [Phase 1]